Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization

Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization

Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2017-01, Vol.45 (1), p.183-184
Hauptverfasser: He, Z.‐H., He, W.‐R., Wu, L.‐L., Zhao, C., Peng, N.‐F., Ahir, B.‐K., Lu, C.‐Y.
Format: Artikel
Sprache:eng
Schlagworte:
Cytokeratin
Hepatocellular carcinoma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.13820